Benjamin J. Parcell
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- SARS-CoV-2 and COVID-19 Research 4
- Epidemiology 13
- Infective Endocarditis Diagnosis and Management 5
- Urinary Tract Infections Management 3
- Pneumonia and Respiratory Infections 2
- Co-authors
- Stephen H. Gillespie (5 shared papers)Matthew T. G. Holden (3 shared papers)G. Phillips (2 shared papers)Peter J. Coote (5 shared papers)Kerry A. Pettigrew (2 shared papers)James D. Chalmers (5 shared papers)G. Orange (1 shared paper)Jane F. Turton (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)Journal of Hospital Infection (4 papers)Antibiotics (3 papers)Journal of Medical Microbiology (3 papers)The Lancet Microbe (2 papers)
- Partner nations
- United KingdomJapanUnited States
In The Last Decade
Benjamin J. Parcell
43 papers receiving 429 citations
Peers
Comparison fields: 5 of 65
- Molecular Medicine 91
- Clinical Biochemistry 61
- Infectious Diseases 151
- Applied Microbiology and Biotechnology 13
- Microbiology 41
Countries citing papers authored by Benjamin J. Parcell
This map shows the geographic impact of Benjamin J. Parcell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Parcell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Parcell more than expected).
Fields of papers citing papers by Benjamin J. Parcell
This network shows the impact of papers produced by Benjamin J. Parcell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Parcell. The network helps show where Benjamin J. Parcell may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin J. Parcell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 38 | |
| 2 | 2016 | 29 | |
| 3 | 2020 | 29 | |
| 4 | 2021 | 28 | |
| 5 | 2014 | 27 | |
| 6 | 2014 | 24 | |
| 7 | 2015 | 21 | |
| 8 | 2019 | 21 | |
| 9 | 2021 | 19 | |
| 10 | 2014 | 17 | |
| 11 | 2024 | 16 | |
| 12 | 2022 | 15 | |
| 13 | 2014 | 13 | |
| 14 | 2017 | 11 | |
| 15 | 2013 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2024 | 9 | |
| 19 | 2013 | 9 | |
| 20 | 2020 | 8 |
About Benjamin J. Parcell
Benjamin J. Parcell is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Clinical Biochemistry and Microbiology, having authored 44 papers that have together received 438 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Urinary Tract Infections Management (3 papers), Bacterial Infections and Vaccines (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Molecular Medicine (91 citations), Clinical Biochemistry (61 citations), Infectious Diseases (151 citations), Applied Microbiology and Biotechnology (13 citations) and Microbiology (41 citations). Benjamin J. Parcell has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Stephen H. Gillespie, Matthew T. G. Holden, G. Phillips, Peter J. Coote, Kerry A. Pettigrew, James D. Chalmers, G. Orange, Jane F. Turton, Samira Bell and Kate Templeton. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Antibiotics, Journal of Medical Microbiology and The Lancet Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.